世界の抗緑内障薬市場規模・現状・予測2021-2027

【英語タイトル】Global Anti-glaucoma Drug Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0391)・商品コード:QY21APR0391
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:99
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、抗緑内障薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(縮瞳薬、ベータ遮断薬、アドレナリン作動薬、炭酸脱水酵素阻害薬、プロスタグランジン誘導体剤、ペネトレート)、用途別市場規模(病院薬局、ドラッグストア、オンライン販売)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・抗緑内障薬の市場動向
・企業の競争状況、市場シェア
・抗緑内障薬の種類別市場規模(縮瞳薬、ベータ遮断薬、アドレナリン作動薬、炭酸脱水酵素阻害薬、プロスタグランジン誘導体剤、ペネトレート)
・抗緑内障薬の用途別市場規模(病院薬局、ドラッグストア、オンライン販売)
・抗緑内障薬の北米市場規模2016-2027(アメリカ、カナダ)
・抗緑内障薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・抗緑内障薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・抗緑内障薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・抗緑内障薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Pfizer、Merck、Allergan、Santen、Alcon、Teva Pharmaceuticals、Fera Pharmaceuticals、Bausch & Lomb, Inc.、Akorn, Inc.)
・結論
【レポートの概要】

Market Analysis and Insights: Global Anti-glaucoma Drug Market
The global Anti-glaucoma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-glaucoma Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-glaucoma Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-glaucoma Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-glaucoma Drug market.

Global Anti-glaucoma Drug Scope and Market Size
Anti-glaucoma Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-glaucoma Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Miosis Drugs
Beta-blocker
Adrenergic Agonists
Carbonic Anhydrase Inhibitor
Prostaglandin Derivative Agent
Penetrates

Segment by Application
Hospital Pharmacy
Drugstore
Online Sales

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Merck
Allergan
Santen
Alcon
Teva Pharmaceuticals
Fera Pharmaceuticals
Bausch & Lomb, Inc.
Akorn, Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-glaucoma Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Miosis Drugs
1.2.3 Beta-blocker
1.2.4 Adrenergic Agonists
1.2.5 Carbonic Anhydrase Inhibitor
1.2.6 Prostaglandin Derivative Agent
1.2.7 Penetrates
1.3 Market by Application
1.3.1 Global Anti-glaucoma Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Drugstore
1.3.4 Online Sales
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-glaucoma Drug Market Perspective (2016-2027)
2.2 Anti-glaucoma Drug Growth Trends by Regions
2.2.1 Anti-glaucoma Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-glaucoma Drug Historic Market Share by Regions (2016-2021)
2.2.3 Anti-glaucoma Drug Forecasted Market Size by Regions (2022-2027)
2.3 Anti-glaucoma Drug Industry Dynamic
2.3.1 Anti-glaucoma Drug Market Trends
2.3.2 Anti-glaucoma Drug Market Drivers
2.3.3 Anti-glaucoma Drug Market Challenges
2.3.4 Anti-glaucoma Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-glaucoma Drug Players by Revenue
3.1.1 Global Top Anti-glaucoma Drug Players by Revenue (2016-2021)
3.1.2 Global Anti-glaucoma Drug Revenue Market Share by Players (2016-2021)
3.2 Global Anti-glaucoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-glaucoma Drug Revenue
3.4 Global Anti-glaucoma Drug Market Concentration Ratio
3.4.1 Global Anti-glaucoma Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-glaucoma Drug Revenue in 2020
3.5 Anti-glaucoma Drug Key Players Head office and Area Served
3.6 Key Players Anti-glaucoma Drug Product Solution and Service
3.7 Date of Enter into Anti-glaucoma Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-glaucoma Drug Breakdown Data by Type
4.1 Global Anti-glaucoma Drug Historic Market Size by Type (2016-2021)
4.2 Global Anti-glaucoma Drug Forecasted Market Size by Type (2022-2027)

5 Anti-glaucoma Drug Breakdown Data by Application
5.1 Global Anti-glaucoma Drug Historic Market Size by Application (2016-2021)
5.2 Global Anti-glaucoma Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-glaucoma Drug Market Size (2016-2027)
6.2 North America Anti-glaucoma Drug Market Size by Type
6.2.1 North America Anti-glaucoma Drug Market Size by Type (2016-2021)
6.2.2 North America Anti-glaucoma Drug Market Size by Type (2022-2027)
6.2.3 North America Anti-glaucoma Drug Market Size by Type (2016-2027)
6.3 North America Anti-glaucoma Drug Market Size by Application
6.3.1 North America Anti-glaucoma Drug Market Size by Application (2016-2021)
6.3.2 North America Anti-glaucoma Drug Market Size by Application (2022-2027)
6.3.3 North America Anti-glaucoma Drug Market Size by Application (2016-2027)
6.4 North America Anti-glaucoma Drug Market Size by Country
6.4.1 North America Anti-glaucoma Drug Market Size by Country (2016-2021)
6.4.2 North America Anti-glaucoma Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Anti-glaucoma Drug Market Size (2016-2027)
7.2 Europe Anti-glaucoma Drug Market Size by Type
7.2.1 Europe Anti-glaucoma Drug Market Size by Type (2016-2021)
7.2.2 Europe Anti-glaucoma Drug Market Size by Type (2022-2027)
7.2.3 Europe Anti-glaucoma Drug Market Size by Type (2016-2027)
7.3 Europe Anti-glaucoma Drug Market Size by Application
7.3.1 Europe Anti-glaucoma Drug Market Size by Application (2016-2021)
7.3.2 Europe Anti-glaucoma Drug Market Size by Application (2022-2027)
7.3.3 Europe Anti-glaucoma Drug Market Size by Application (2016-2027)
7.4 Europe Anti-glaucoma Drug Market Size by Country
7.4.1 Europe Anti-glaucoma Drug Market Size by Country (2016-2021)
7.4.2 Europe Anti-glaucoma Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-glaucoma Drug Market Size (2016-2027)
8.2 Asia-Pacific Anti-glaucoma Drug Market Size by Type
8.2.1 Asia-Pacific Anti-glaucoma Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-glaucoma Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-glaucoma Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-glaucoma Drug Market Size by Application
8.3.1 Asia-Pacific Anti-glaucoma Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-glaucoma Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-glaucoma Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-glaucoma Drug Market Size by Region
8.4.1 Asia-Pacific Anti-glaucoma Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-glaucoma Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-glaucoma Drug Market Size (2016-2027)
9.2 Latin America Anti-glaucoma Drug Market Size by Type
9.2.1 Latin America Anti-glaucoma Drug Market Size by Type (2016-2021)
9.2.2 Latin America Anti-glaucoma Drug Market Size by Type (2022-2027)
9.2.3 Latin America Anti-glaucoma Drug Market Size by Type (2016-2027)
9.3 Latin America Anti-glaucoma Drug Market Size by Application
9.3.1 Latin America Anti-glaucoma Drug Market Size by Application (2016-2021)
9.3.2 Latin America Anti-glaucoma Drug Market Size by Application (2022-2027)
9.3.3 Latin America Anti-glaucoma Drug Market Size by Application (2016-2027)
9.4 Latin America Anti-glaucoma Drug Market Size by Country
9.4.1 Latin America Anti-glaucoma Drug Market Size by Country (2016-2021)
9.4.2 Latin America Anti-glaucoma Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-glaucoma Drug Market Size (2016-2027)
10.2 Middle East & Africa Anti-glaucoma Drug Market Size by Type
10.2.1 Middle East & Africa Anti-glaucoma Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-glaucoma Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-glaucoma Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-glaucoma Drug Market Size by Application
10.3.1 Middle East & Africa Anti-glaucoma Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-glaucoma Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-glaucoma Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-glaucoma Drug Market Size by Country
10.4.1 Middle East & Africa Anti-glaucoma Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-glaucoma Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Anti-glaucoma Drug Introduction
11.1.4 Pfizer Revenue in Anti-glaucoma Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Anti-glaucoma Drug Introduction
11.2.4 Merck Revenue in Anti-glaucoma Drug Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Anti-glaucoma Drug Introduction
11.3.4 Allergan Revenue in Anti-glaucoma Drug Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 Santen
11.4.1 Santen Company Details
11.4.2 Santen Business Overview
11.4.3 Santen Anti-glaucoma Drug Introduction
11.4.4 Santen Revenue in Anti-glaucoma Drug Business (2016-2021)
11.4.5 Santen Recent Development
11.5 Alcon
11.5.1 Alcon Company Details
11.5.2 Alcon Business Overview
11.5.3 Alcon Anti-glaucoma Drug Introduction
11.5.4 Alcon Revenue in Anti-glaucoma Drug Business (2016-2021)
11.5.5 Alcon Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Anti-glaucoma Drug Introduction
11.6.4 Teva Pharmaceuticals Revenue in Anti-glaucoma Drug Business (2016-2021)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Fera Pharmaceuticals
11.7.1 Fera Pharmaceuticals Company Details
11.7.2 Fera Pharmaceuticals Business Overview
11.7.3 Fera Pharmaceuticals Anti-glaucoma Drug Introduction
11.7.4 Fera Pharmaceuticals Revenue in Anti-glaucoma Drug Business (2016-2021)
11.7.5 Fera Pharmaceuticals Recent Development
11.8 Bausch & Lomb, Inc.
11.8.1 Bausch & Lomb, Inc. Company Details
11.8.2 Bausch & Lomb, Inc. Business Overview
11.8.3 Bausch & Lomb, Inc. Anti-glaucoma Drug Introduction
11.8.4 Bausch & Lomb, Inc. Revenue in Anti-glaucoma Drug Business (2016-2021)
11.8.5 Bausch & Lomb, Inc. Recent Development
11.9 Akorn, Inc.
11.9.1 Akorn, Inc. Company Details
11.9.2 Akorn, Inc. Business Overview
11.9.3 Akorn, Inc. Anti-glaucoma Drug Introduction
11.9.4 Akorn, Inc. Revenue in Anti-glaucoma Drug Business (2016-2021)
11.9.5 Akorn, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti-glaucoma Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Miosis Drugs
Table 3. Key Players of Beta-blocker
Table 4. Key Players of Adrenergic Agonists
Table 5. Key Players of Carbonic Anhydrase Inhibitor
Table 6. Key Players of Prostaglandin Derivative Agent
Table 7. Key Players of Penetrates
Table 8. Global Anti-glaucoma Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Anti-glaucoma Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Anti-glaucoma Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Anti-glaucoma Drug Market Share by Regions (2016-2021)
Table 12. Global Anti-glaucoma Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Anti-glaucoma Drug Market Share by Regions (2022-2027)
Table 14. Anti-glaucoma Drug Market Trends
Table 15. Anti-glaucoma Drug Market Drivers
Table 16. Anti-glaucoma Drug Market Challenges
Table 17. Anti-glaucoma Drug Market Restraints
Table 18. Global Anti-glaucoma Drug Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Anti-glaucoma Drug Market Share by Players (2016-2021)
Table 20. Global Top Anti-glaucoma Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-glaucoma Drug as of 2020)
Table 21. Ranking of Global Top Anti-glaucoma Drug Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Anti-glaucoma Drug Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Anti-glaucoma Drug Product Solution and Service
Table 25. Date of Enter into Anti-glaucoma Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Anti-glaucoma Drug Revenue Market Share by Type (2016-2021)
Table 29. Global Anti-glaucoma Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Anti-glaucoma Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Anti-glaucoma Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Anti-glaucoma Drug Revenue Market Share by Application (2016-2021)
Table 33. Global Anti-glaucoma Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Anti-glaucoma Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Anti-glaucoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Anti-glaucoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Anti-glaucoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Anti-glaucoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Anti-glaucoma Drug Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Anti-glaucoma Drug Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Anti-glaucoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Anti-glaucoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anti-glaucoma Drug Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Anti-glaucoma Drug Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Anti-glaucoma Drug Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Anti-glaucoma Drug Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Anti-glaucoma Drug Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Anti-glaucoma Drug Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Anti-glaucoma Drug Product
Table 68. Pfizer Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Merck Company Details
Table 71. Merck Business Overview
Table 72. Merck Anti-glaucoma Drug Product
Table 73. Merck Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 74. Merck Recent Development
Table 75. Allergan Company Details
Table 76. Allergan Business Overview
Table 77. Allergan Anti-glaucoma Drug Product
Table 78. Allergan Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 79. Allergan Recent Development
Table 80. Santen Company Details
Table 81. Santen Business Overview
Table 82. Santen Anti-glaucoma Drug Product
Table 83. Santen Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 84. Santen Recent Development
Table 85. Alcon Company Details
Table 86. Alcon Business Overview
Table 87. Alcon Anti-glaucoma Drug Product
Table 88. Alcon Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 89. Alcon Recent Development
Table 90. Teva Pharmaceuticals Company Details
Table 91. Teva Pharmaceuticals Business Overview
Table 92. Teva Pharmaceuticals Anti-glaucoma Drug Product
Table 93. Teva Pharmaceuticals Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 94. Teva Pharmaceuticals Recent Development
Table 95. Fera Pharmaceuticals Company Details
Table 96. Fera Pharmaceuticals Business Overview
Table 97. Fera Pharmaceuticals Anti-glaucoma Drug Product
Table 98. Fera Pharmaceuticals Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 99. Fera Pharmaceuticals Recent Development
Table 100. Bausch & Lomb, Inc. Company Details
Table 101. Bausch & Lomb, Inc. Business Overview
Table 102. Bausch & Lomb, Inc. Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 103. Bausch & Lomb, Inc. Recent Development
Table 104. Akorn, Inc. Company Details
Table 105. Akorn, Inc. Business Overview
Table 106. Akorn, Inc. Anti-glaucoma Drug Product
Table 107. Akorn, Inc. Revenue in Anti-glaucoma Drug Business (2016-2021) & (US$ Million)
Table 108. Akorn, Inc. Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-glaucoma Drug Market Share by Type: 2020 VS 2027
Figure 2. Miosis Drugs Features
Figure 3. Beta-blocker Features
Figure 4. Adrenergic Agonists Features
Figure 5. Carbonic Anhydrase Inhibitor Features
Figure 6. Prostaglandin Derivative Agent Features
Figure 7. Penetrates Features
Figure 8. Global Anti-glaucoma Drug Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Drugstore Case Studies
Figure 11. Online Sales Case Studies
Figure 12. Anti-glaucoma Drug Report Years Considered
Figure 13. Global Anti-glaucoma Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Anti-glaucoma Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Anti-glaucoma Drug Market Share by Regions: 2020 VS 2027
Figure 16. Global Anti-glaucoma Drug Market Share by Regions (2022-2027)
Figure 17. Global Anti-glaucoma Drug Market Share by Players in 2020
Figure 18. Global Top Anti-glaucoma Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-glaucoma Drug as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Anti-glaucoma Drug Revenue in 2020
Figure 20. Global Anti-glaucoma Drug Revenue Market Share by Type (2016-2021)
Figure 21. Global Anti-glaucoma Drug Revenue Market Share by Type (2022-2027)
Figure 22. North America Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 24. North America Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 25. North America Anti-glaucoma Drug Market Share by Country (2016-2027)
Figure 26. United States Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 30. Europe Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 31. Europe Anti-glaucoma Drug Market Share by Country (2016-2027)
Figure 32. Germany Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Anti-glaucoma Drug Market Share by Region (2016-2027)
Figure 42. China Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 50. Latin America Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 51. Latin America Anti-glaucoma Drug Market Share by Country (2016-2027)
Figure 52. Mexico Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Anti-glaucoma Drug Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Anti-glaucoma Drug Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Anti-glaucoma Drug Market Share by Country (2016-2027)
Figure 58. Turkey Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Anti-glaucoma Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 63. Allergan Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 64. Santen Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 65. Alcon Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 67. Fera Pharmaceuticals Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 68. Bausch & Lomb, Inc. Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 69. Akorn, Inc. Revenue Growth Rate in Anti-glaucoma Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed


【掲載企業】

Pfizer、Merck、Allergan、Santen、Alcon、Teva Pharmaceuticals、Fera Pharmaceuticals、Bausch & Lomb, Inc.、Akorn, Inc.

★調査レポート[世界の抗緑内障薬市場規模・現状・予測2021-2027] (コード:QY21APR0391)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗緑内障薬市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆